BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33073585)

  • 1. The complicated role of mitochondria in the podocyte.
    Gujarati NA; Vasquez JM; Bogenhagen DF; Mallipattu SK
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F955-F965. PubMed ID: 33073585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy.
    Gong W; Song J; Liang J; Ma H; Wu W; Zhang Y; Yang L; Huang S; Jia Z; Zhang A
    Kidney Int; 2021 Apr; 99(4):854-869. PubMed ID: 33181155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofactors regulating mitochondrial function and dynamics in podocytes and podocytopathies.
    Hejazian SM; Ardalan M; Hosseiniyan Khatibi SM; Rahbar Saadat Y; Barzegari A; Gueguen V; Meddahi-Pellé A; Anagnostou F; Zununi Vahed S; Pavon-Djavid G
    J Cell Physiol; 2023 Oct; 238(10):2206-2227. PubMed ID: 37659096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte energy metabolism and glomerular diseases.
    Imasawa T; Rossignol R
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2109-18. PubMed ID: 23806869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury.
    Su M; Dhoopun AR; Yuan Y; Huang S; Zhu C; Ding G; Liu B; Yang T; Zhang A
    Am J Physiol Renal Physiol; 2013 Aug; 305(4):F520-31. PubMed ID: 23761667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney Disease.
    Popovic ZV; Bestvater F; Krunic D; Krämer BK; Bergner R; Löffler C; Hocher B; Marx A; Porubsky S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy and podocytopathy.
    Ponticelli C; Moroni G; Reggiani F
    Nephrol Dial Transplant; 2023 Aug; 38(9):1931-1939. PubMed ID: 36708169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
    Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
    Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
    Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Podocyte Biology.
    Garg P
    Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could Autophagic Exhaustion Be a Final Common Pathway for Podocytopathy in FSGS?
    Venkatachalam MA
    J Am Soc Nephrol; 2015 May; 26(5):999-1001. PubMed ID: 25406340
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.
    Yuan Y; Huang S; Wang W; Wang Y; Zhang P; Zhu C; Ding G; Liu B; Yang T; Zhang A
    Kidney Int; 2012 Oct; 82(7):771-89. PubMed ID: 22648295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many ways can a podocyte die?
    Tharaux PL; Huber TB
    Semin Nephrol; 2012 Jul; 32(4):394-404. PubMed ID: 22958494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte injury and its consequences.
    Nagata M
    Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases.
    Liu T; Yang L; Mao H; Ma F; Wang Y; Li S; Li P; Zhan Y
    Biomed Pharmacother; 2022 Nov; 155():113620. PubMed ID: 36122519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The podocyte power-plant disaster and its contribution to glomerulopathy.
    Müller-Deile J; Schiffer M
    Front Endocrinol (Lausanne); 2014; 5():209. PubMed ID: 25566185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 6 regulates mitochondrial function in the kidney.
    Mallipattu SK; Horne SJ; D'Agati V; Narla G; Liu R; Frohman MA; Dickman K; Chen EY; Ma'ayan A; Bialkowska AB; Ghaleb AM; Nandan MO; Jain MK; Daehn I; Chuang PY; Yang VW; He JC
    J Clin Invest; 2015 Mar; 125(3):1347-61. PubMed ID: 25689250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.